Verwijs Marinus

CHIEF TECHNICAL OFFICERAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed Mar 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$138K
Net Open-Market Flow
-$138K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 19, 2024Sell(S)3K$25.68$65K3K
Mar 19, 2024Option exercise(M)5K$14.59$77K5K
Mar 19, 2024Sell(S)3K$26.46$73K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 19, 2024Option exercise(M)5K$085K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-008772) within minutes of acceptance. Every field above traces to the original document. Verify it directly: